Skip to main content

Table 2 Dose profiles of each organs

From: Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas

   Dose (Gy) Fraction of cases decrease with respect to CRT (%)
   CRT IMRT PBT IMRT PBT
Liver Mean 14.2 13.3 6.3 60 100
  D 5% 32.1 25.3 22.8 100 100
  D50% 10.0 12.8 3.5 40 100
  D90% 2.8 4.1 0.2 0 100
Stomach Mean 20.3 21.5 11.8 60 80
  D 5% 32.9 31.7 20.4 80 100
  D50% 17.7 20.7 5.0 60 100
  D90% 10.5 13.5 2.2 40 100
Small intestine Mean 9.4 11.2 3.4 20 100
  D 5% 31.4 30.6 21.7 60 100
  D50% 3.7 7.6 1.4 40 100
  D90% 0.7 1.1 0.0 0 100
Bone Mean 20.5 21.7 16.9 20 80
  D 5% 32.2 33.0 27.5 0 100
  D50% 21.8 24.7 7.7 40 100
  D90% 1.3 4.3 0.1 0 100
Pancreas Mean 28.2 28.2 21.2 60 80
  D 5% 32.3 33.2 30.6 20 100
  D50% 31.5 31.1 20.9 60 80
  D90% 17.0 16.8 11.9 40 80
Colon Mean 9.9 11.2 2.1 60 100
  D 5% 31.8 26.6 14.0 100 100
  D50% 8.5 10.4 0.1 20 100
  D90% 0.7 0.9 0.0 0 100